Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients. | Cost Eff Resour Alloc;17: 26, 2019. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Biblioteca Virtual en Salud

BVS - Literatura Cientifica y Técnica

Localizar descriptor de asunto Búsqueda Avanzada

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients.

Punekar, Yogesh Suresh; Guo, Na; Tremblay, Gabriel; Piercy, James; Holbrook, Tim; Young, Benjamin.

Punekar YS; 1ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS UK.
Guo N; 2GlaxoSmithKline, Shanghai, China.
Tremblay G; Purple Squirrel Economics, New York, USA.
Piercy J; Adelphi Real World, Bollington, UK.
Holbrook T; Adelphi Real World, Bollington, UK.
Young B; IAPAC, Washington, DC USA.

Cost Eff Resour Alloc ; 17: 26, 2019.

Article en En | MEDLINE | ID: mdl-31827410

Palabras clave

China; Cost effectiveness; Dolutegravir; Economic analyses; Treatment naive

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Idioma: En Año: 2019 Tipo del documento: Article

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Idioma: En Año: 2019 Tipo del documento: Article